- Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading...
* Acknowledged for strong environmental, social, and governance (ESG) performance and continued c...
INCHEON, South Korea, Dec. 3, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global con...
* The company will provide manufacturing services through 2031 in deals worth overUSD 668 million...
* The company adds new ISO certification for compliance management and certified to updated stand...
* Recorded Q3'24 consolidated revenue of KRW 1.2 trillion * Recorded Q3'24 consolidated operatin...
* S-HiConTM is designed to maximize drug delivery and stability through high-concentration formul...
* Samsung Biologics showcases new innovative development platforms – S-AfuCHO TM and S-OptiChargeT...
* Samsung Biologics to embed PSCI principles into business practices for responsible value chain ...
* Recorded Q1'24 consolidated revenue of KRW 946.9 billion * Recorded Q1'24 consolidated operati...
INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced t...
- Distinguished industry leaders with extensive track records in quality assurance and regulatory a...
* Recorded Q2'23 consolidated revenue of KRW 866.2 billion * Recorded Q2'23 consolidated operati...
INCHEON, South Korea, July 18, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940), a global contr...
- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest ...
* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operat...
* The company plans to begin construction in the first half of 2023 and commence operations in 20...
* Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit ofKRW 312.8 billion....
* Samsung Biologics is one of 19 companies to have been awarded the 2022 Terra Carta Seal. * Th...
* Recorded consolidated revenue of KRW 873 billion in Q3'22 * Recorded consolidated operating pr...